These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12695282)

  • 41. Revascularization options in patients with chronic kidney disease.
    Ashrith G; Elayda MA; Wilson JM
    Tex Heart Inst J; 2010; 37(1):9-18. PubMed ID: 20200622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
    Kuller LH
    Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.
    Buntaine AJ; Shah B; Lorin JD; Sedlis SP
    Curr Cardiol Rep; 2016 Aug; 18(8):79. PubMed ID: 27339854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utilization of reperfusion therapy in the Myocardial INfarction Triggers and Onset in JoRdan (MINTOR) study.
    Hammoudeh AJ; Izraiq M; Ismail Y; Tabbalat R; El-Harassis A; Al-Tarawneh H; Hamdan H; Al-Mousa E
    Int J Cardiol; 2007 Nov; 122(2):156-7. PubMed ID: 17321618
    [No Abstract]   [Full Text] [Related]  

  • 46. Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries.
    Nallamothu BK; Rogers MA; Chernew ME; Krumholz HM; Eagle KA; Birkmeyer JD
    JAMA; 2007 Mar; 297(9):962-8. PubMed ID: 17341710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
    Henderson RA; Timmis AD
    G Ital Cardiol (Rome); 2012 Apr; 13(4):244-53. PubMed ID: 22495641
    [No Abstract]   [Full Text] [Related]  

  • 48. Racial variation in the use of coronary-revascularization procedures.
    Barnhart JM; Wassertheil-Smoller S
    N Engl J Med; 1997 Jul; 337(2):131-2. PubMed ID: 9221341
    [No Abstract]   [Full Text] [Related]  

  • 49. Hybrid coronary revascularization: which patients? When? How?
    Bonatti J; Lehr E; Vesely MR; Friedrich G; Bonaros N; Zimrin D
    Curr Opin Cardiol; 2010 Nov; 25(6):568-74. PubMed ID: 20885316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated coronary revascularization.
    Cohen HA; Zenati M
    J Invasive Cardiol; 1999 Mar; 11(3):184-90; discussion 190-1. PubMed ID: 10745509
    [No Abstract]   [Full Text] [Related]  

  • 52. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Heart; 2011 Oct; 97(19):1552-9. PubMed ID: 21900584
    [No Abstract]   [Full Text] [Related]  

  • 53. Coronary artery bypass grafting (CABG): reassessing efficacy, safety, and cost.
    Cundiff DK
    MedGenMed; 2002 Jun; 4(2):7. PubMed ID: 12145567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
    Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
    Circulation; 2014 Apr; 129(16):e460-1. PubMed ID: 24753557
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
    Breeman A; Hordijk-Trion M; Lenzen M; Hoeks S; Ottervanger JP; Bertrand ME; Sechtem U; Zaliunas R; Legrand V; de Boer MJ; Stahle E; Mercado N; Wijns W; Boersma E;
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1001-9. PubMed ID: 17059915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX.
    Hahalis G; Dangas G; Davlouros P; Alexopoulos D
    Int J Cardiol; 2011 Dec; 153(2):126-34. PubMed ID: 21474193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. With FREEDOM comes responsibility.
    Murray SW
    J Invasive Cardiol; 2013 Jan; 25(1):1. PubMed ID: 23293166
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Goldfine AB; Fonseca V
    Circulation; 2010 Jun; 121(22):2447-9. PubMed ID: 20530022
    [No Abstract]   [Full Text] [Related]  

  • 59. Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents.
    Halpern MT; Lacey M; Clark MA; Valentin MA
    BMC Cardiovasc Disord; 2004 Dec; 4():23. PubMed ID: 15596004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Myocardial revascularization in the early XXIst century: less and less bypass indications].
    Monassier JP; Monassier F
    Presse Med; 2008 Nov; 37(11):1575-9. PubMed ID: 18786805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.